Literature DB >> 8566822

Immunohistochemical localization of epidermal growth factor receptor and epithelial antigen in tumors of the human conjunctiva, eyelid, lacrimal gland, and orbit.

T Kodama1, S Hayasaka, T Setogawa.   

Abstract

BACKGROUND: Increased numbers of epidermal growth factor (EGF) receptors are observed in squamous cell carcinomas of human lung, head, neck, and cervix. We studied the presence of EGF receptors and epithelial antigen in some ophthalmic lesions.
METHODS: Immunohistochemical staining for EGF receptors was assessed in tumors of human conjunctiva, eyelid, lacrimal glands, and orbit with monoclonal antibodies (EGF-R1 and clone 29.1). Reactivity of Ber-EP4, which recognizes epithelial antigen, was also examined.
RESULTS: Strong staining of EGF-R1 and clone 29.1 and weak to moderate staining of Ber-EP4 were demonstrated in conjunctival squamous cell carcinomas. Cell membranes of conjunctival papilloma were moderately or strongly stained with these antibodies. Ductal components in sebaceous gland adenoma of the eyelid and pleomorphic adenoma of the lacrimal gland were positively stained. The antibodies did not bind to reactive lymphoid hyperplasia of the orbit and Wegener's granulomatosis. Relatively good correlation for immunostaining reaction was observed among EGF-R1, clone 29.1, and Ber-EP4 in each tumor.
CONCLUSION: Immunostaining using EGF-R1, clone 29.1, and Ber-EP4 may be useful in differentiating epithelial tumors from non-epithelial lesions. Strong immunostaining for EGF receptor may be the hallmark of epidermoid malignancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566822     DOI: 10.1007/bf00164668

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas.

Authors:  B Ozanne; C S Richards; F Hendler; D Burns; B Gusterson
Journal:  J Pathol       Date:  1986-05       Impact factor: 7.996

2.  Presence of epidermal growth factor in human tears.

Authors:  Y Ohashi; M Motokura; Y Kinoshita; T Mano; H Watanabe; S Kinoshita; R Manabe; K Oshiden; C Yanaihara
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-08       Impact factor: 4.799

3.  Kinetics of corneal epithelial regeneration and epidermal growth factor.

Authors:  P C Ho; W H Davis; J H Elliott; S Cohen
Journal:  Invest Ophthalmol       Date:  1974-10

4.  Selective binding of the epidermal growth factor and its specific effects on the epithelial cells of the cornea.

Authors:  L Frati; S Daniele; A Delogu; I Covelli
Journal:  Exp Eye Res       Date:  1972-09       Impact factor: 3.467

5.  Localizations of epidermal growth factor receptor and proliferating cell nuclear antigen during corneal wound healing.

Authors:  T Murata; T Ishibashi; H Inomata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-02       Impact factor: 3.117

Review 6.  The epidermal growth factor (EGF).

Authors:  S Cohen
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860

7.  Epidermal growth factor receptors in lung tumours.

Authors:  M S Berger; W J Gullick; C Greenfield; S Evans; B J Addis; M D Waterfield
Journal:  J Pathol       Date:  1987-08       Impact factor: 7.996

8.  Stimulatory effects of fibronectin and EGF on migration of corneal epithelial cells.

Authors:  K Watanabe; S Nakagawa; T Nishida
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-02       Impact factor: 4.799

9.  Epidermal growth factor in alkali-burned corneal epithelial wound healing.

Authors:  G Singh; C S Foster
Journal:  Am J Ophthalmol       Date:  1987-06-15       Impact factor: 5.258

10.  Human recombinant epidermal growth factor in experimental corneal wound healing.

Authors:  R K Brazzell; M E Stern; J V Aquavella; R W Beuerman; L Baird
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-02       Impact factor: 4.799

View more
  2 in total

1.  Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.

Authors:  Min Joung Lee; Namju Kim; Ho-Kyung Choung; Ji-Young Choe; Sang In Khwarg; Ji Eun Kim
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-04       Impact factor: 4.553

2.  Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cells.

Authors:  Y Tan; K H Chiow; D Huang; S H Wong
Journal:  Br J Pharmacol       Date:  2010-02-19       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.